Indian American Anjali Pandey, head of medicinal chemistry at Sudo Biosciences, and an accomplished biopharmaceutical R&D leader, scientist, and inventor, says artificial intelligence (AI) will not only change the time course taken by biotech or pharma industries to drug discovery, but will also bring the cost down.
